Serum Institute of India

Representational image. Photo: Collected
Covid-19 in Bangladesh

Serum to export vaccine to Bangladesh by 25 Jan: Beximco

"Beximco has completed 75% of its preparation for vaccine management"

India ready for rollout of Covid-19 vaccines within 10 days
Coronavirus chronicle

India ready for rollout of Covid-19 vaccines within 10 days

Serum CEO Adar Poonawalla/Courtesy
Coronavirus chronicle

Serum is permitted to export vaccines to all countries: CEO Poonawalla 

Foreign Minister Dr AK Abdul Momen Photo: Collected
Covid-19 in Bangladesh

Serum CEO’s remark on vaccine export ban is personal, Momen says quoting Delhi

Sinovac Covid-19 vaccine. Photo/TBS
Bangladesh

Not allowing the Chinese vaccine was the wrong decision: Prof Nazrul

Photo: Collected
Stocks

Beximco Pharma’s share price falls after India bans vaccine export

UK clearance to Oxford vaccine paves way for Bangladesh
Coronavirus chronicle

UK clearance to Oxford vaccine paves way for Bangladesh

Representational photo.
Coronavirus chronicle

Serum Institute request for emergency use of Oxford vaccine to be considered today

FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India, Pune, India, November 30, 2020. REUTERS/Francis Mascarenhas
Coronavirus chronicle

India's Serum Institute expects approval for AstraZeneca vaccine in days

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters
Coronavirus chronicle

India's Serum Institute seeks emergency use nod for AstraZeneca's Covid-19 vaccine

The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters
World+Biz

Serum Institute CEO Adar Poonawalla named 1 of 6 ‘Asians of the year’

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha/File Photo/File Photo
Coronavirus chronicle

Serum Institute says its vaccine candidate Covishield safe and immunogenic

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha/File Photo/File Photo
Coronavirus chronicle

Serum Institute CEO sees AstraZeneca's vaccine as "very good" candidate